Experts advise that individuals taking oral GLP-1 medications like Wegovy should avoid consuming coffee or tea at the same time to ensure proper absorption of the medication. The FDA recommends taking Wegovy on an empty stomach with water and waiting at least 30 minutes before c…
Researchers from East China Normal University have developed a probiotic that can sense and respond to glucose levels, potentially transforming type 2 diabetes treatment. This inn…
A California shopper's viral reaction to a 'GLP-1-friendly' frozen pizza has raised questions about the implications of such labeling. The pizza, part of Nestlé's Vital Pursuit li…
The death of 19-year-old Josephine Nasr, a law student in London, has sparked serious concerns regarding the safety of tirzepatide, a GLP-1 weight loss drug. Following her prescri…
Nestle is leveraging the rise of GLP-1 weight-loss drugs to create new products aimed at consumers taking medications like Ozempic and Wegovy. The company is utilizing artificial…
A recent study published in the Journal of the American Medical Association forecasts that nearly half of U.S. adults will have obesity by 2035, highlighting significant dispariti…
Older adults taking GLP-1 medications such as Ozempic and Wegovy should focus on adequate protein, calcium, and vitamin D intake to maintain muscle and bone health during weight l…
Researchers at the University of Cambridge have discovered that both activating and blocking the glucose-dependent insulinotropic polypeptide receptor (GIPR) in different brain re…
The emergence of GLP-1 weight loss drugs, such as Ozempic and Wegovy, has transformed the landscape of obesity treatment, generating significant revenue for manufacturers and spar…
Recent research has revealed that semaglutide, a popular weight-loss drug, may operate through mechanisms involving hunger neurons, challenging previous understandings of its effe…
U.S. News & World Report has released its first ratings of telehealth platforms offering GLP-1 medications for weight loss, highlighting the importance of clinical oversight and p…
Recent research indicates that GLP-1 agonists, such as Ozempic, may not only aid in weight loss but also reduce cravings for addictive substances like alcohol. This effect is link…
As 'Ozempic face' becomes a trending concern after weight loss from GLP-1 medications, surgeons adapt by offering innovative treatments to restore youthful facial volume and featu…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
Eli Lilly is targeting a revenue milestone of $100 billion by fiscal 2026, supported by strong growth in its incretin franchise and a bullish price target of $1,480. The company's…